New Antipsychotic Targets a Different Combination of Neurotransmitters in Schizophrenia.

The Washington Post (11/2, Musgrove http://tinyurl.com/new-antipsychotic-Fanapt) reports that , “Early next year, if all goes according to plan, doctors will be able to prescribe a new antipsychotic drug for patients with schizophrenia.  Fanapt, like other antipsychotic drugs, controls the way information is carried from one nerve cell to another and reduces the activities of some brain activity associated with schizophrenia. The compound blocks a different combination of neurotransmitters than earlier-generation antipsychotic drugs.  Fanapt targets a more relevant set of neurotransmitter receptors, so that patients are likely to suffer fewer side effects than with other medications.

Read Full Post »